First Manhattan CO Dexcom Inc Transaction History

First Manhattan CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $43,403 - $53,238	-380 Reduced 21.4%	1,396 $193,000
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $9,511 - $15,644	126 Added 7.64%	1,776 $220,000
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $258 - $413	3 Added 0.18%	1,650 $153,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $12,034 - $14,014	107 Added 6.95%	1,647 $211,000
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $39,520 - $46,709	380 Added 32.76%	1,540 $178,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $64,584 - $93,229	760 Added 190.0%	1,160 $131,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $20,397 - $39,866	300 Added 300.0%	400 $29,000
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $4,239 - $5,237	50 Added 100.0%	100 $35,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $4,106 - $4,856	-43 Reduced 46.24%	50 $20,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $3,134 - $5,267	50 Added 116.28%	93 $37,000
Q1 2020 May 06, 2020	BUY	$47.79 - $75.63 $2,054 - $3,252	43 New	43 $11,000
Q1 2018 Apr 20, 2018	SELL	$13.06 - $18.54 $50,920 - $72,287	-3,899 Closed	0 $0
Q4 2017 Jan 22, 2018	BUY	$11.12 - $15.38 $43,356 - $59,966	3,899	3,899 $223,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.